Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease
Drug Discovery Today - Netherlands
doi 10.1016/j.drudis.2013.09.005
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Elsevier BV